Talat Imran
Talat Imran is a healthcare-focused executive, entrepreneur, and investor. Currently, Talat serves as Chief Executive Officer and director for Rani Therapeutics Holdings, Inc., a biotech company that has developed a unique approach for the oral delivery of large molecules including peptides, proteins, and antibodies. Previously, he was a managing director at InCube Ventures and VHM Ventures. Talat holds a bachelor's degree in computer science. Outside of healthcare, Talat is a musician, an avid gardener, and a fledgling apiarist.
-
MedCity Influencers, BioPharma
Closing the Oral Drug Gap
Patients are driving the push away from needles, and there are a number of novel approaches attempting to solve the difficult task of transforming biologics into orally administered treatments.
-
MedCity Influencers, BioPharma
The Power of Patient Preference in Shaping the Drug Delivery Market
Demand for alternative drug delivery methods has the potential to reshape therapeutic markets and improve clinical outcomes. New innovations, especially oral alternatives, are poised to drive broad changes across the entire sector.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
